A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BAL / bronchoalveolar

[Related PubMed/MEDLINE]
Total Number of Papers: 80
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BAL  (>> Co-occurring Abbreviation)
Long Form:   bronchoalveolar
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Successful treatment of Ureaplasma-induced hyperammonemia syndrome post-lung transplant. ---
2018 Acute eosinophilic pneumonia in the deployed military setting. AEP, LRMC
2018 GM-CSF overexpression after influenza a virus infection prevents mortality and moderates M1-like airway monocyte/macrophage polarization. DTGM
2018 Predominance of non-fumigatus Aspergillus species among patients suspected to pulmonary aspergillosis in a tropical and subtropical region of the Middle East. ICU, IPA, PA
2017 Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammation. ---
2017 Bronchoalveolar Lavage Microvesicles Protect Burn-Injured Mice from Pulmonary Infection. MVs, Sph
2017 Comparative pharmacokinetics of minocycline in foals and adult horses. CSF, i.v, IG, PELF
2017 Inhibition of MicroRNA-21 by an antagomir ameliorates allergic inflammation in a mouse model of asthma. AHR, miR-21, OVA
2017 NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding Flagellin. i.n, MLN, rMVA
10  2017 Persistent Bacterial Bronchitis: Time to Venture beyond the Umbrella. PBB
11  2016 Comparison of 1,3-beta-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients. BDG, GM, ICU, IPA
12  2015 Abnormal epithelial structure and chronic lung inflammation after repair of chlorine-induced airway injury. ---
13  2014 Receptor Interacting Protein 2 (RIP2) Is Dispensable for OVA-Induced Airway Inflammation in Mice. OVA, RIP2
14  2014 Toll‑like receptor 2 promotes bacterial clearance during the initial stage of pulmonary infection with Acinetobacter baumannii. TLR2, WT
15  2013 Comprehensive analysis of MHC ligands in clinical material by immunoaffinity-mass spectrometry. APC, MHC
16  2013 Significant decline in Galactomannan Signal during storage of clinical serum samples. EDTA, GM, LT, ST
17  2012 A new experimental polytrauma model in rats: molecular characterization of the early inflammatory response. CHI, ChT, PT
18  2012 Evaluation of lung injury and respiratory mechanics in a rat model of acute pancreatitis complicated with endotoxin. ALI, AP, MPO
19  2011 Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection. AZI, BOS, LTRs
20  2011 Elastases from inflammatory and dendritic cells mediate ultrafine carbon black induced acute lung destruction in mice. COPD, DCs
21  2011 Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor. VEGF
22  2010 Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD. COPD
23  2010 Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction. GM, IA
24  2010 Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis. EMT, IPF, PAI-1, PAI-1, siRNA, TGF-beta
25  2010 The pathogen of ventilator-associated pneumonia does not influence the mortality rate of surgical intensive care unit patients treated with a rotational antibiotic system. AIT, APACHE, CFU, ICU, LGNB, NGNB, VAP
26  2009 CD4+ cells are required for chronic eosinophilic lung inflammation but not airway remodeling. OVA
27  2009 IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo--effects of anti-inflammatory pharmacotherapy. IL
28  2009 Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis. IPF
29  2009 Radiological findings of early invasive pulmonary aspergillosis in immune-compromised patients. Asp, CT, IPA, PCR
30  2008 Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles. HPLC
31  2008 Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection. PppA
32  2008 PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells. qRT-PCR
33  2008 The nociceptin/orphanin FQ-NOP receptor antagonist effects on an animal model of sepsis. CLP, N/OFQ, NOP
34  2007 Multiple chemokine receptors, including CCR6 and CXCR3, regulate antigen-induced T cell homing to the human asthmatic airway. ---
35  2007 Patterns and dynamics of airway colonisation in mechanically-ventilated patients. VAP
36  2007 Pharmacokinetics of oral doxycycline and concentrations in body fluids and bronchoalveolar cells of foals. i.g, PELF
37  2006 Effects of inhaled eotaxin on airway function and inflammatory cell influx in sensitised and non-sensitised guinea pigs. AHR, LAR
38  2006 Expression of CCX CKR in pulmonary sarcoidosis. ---
39  2006 Expression of transforming growth factor beta (TGF-b1) by human preterm lung inflammatory cells. BPD, LPS, TGF-beta1
40  2006 Lack of clinical efficacy of a phosphodiesterase-4 inhibitor for treatment of heaves in horses. PDE4, TNF
41  2006 Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals. i.g, PELF
42  2005 Comparative pulmonary toxicity inhalation and instillation studies with different TiO2 particle formulations: impact of surface treatments on particle toxicity. ---
43  2004 Changes in bronchoalveolar lavage cells after intratracheal instillation of dimethyl selenide in mice. DMSe
44  2004 Time-dependent apoptosis of alveolar macrophages from rats exposed to bleomycin: involvement of tnf receptor 2. AM, BLM, cIAP1, PARP, TNF-a, TRAF2
45  2003 Impaired host defense to Klebsiella pneumoniae infection in mice treated with the PDE4 inhibitor rolipram. IL-10, KC, TNF-alpha
46  2003 Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation. IL-6, MIP-2, NO, SCD, TNF-alpha
47  2002 Beryllium induces apoptosis in human lung macrophages. CBD
48  2002 Comparative pulmonary toxicity of blasting sand and five substitute abrasive blasting agents. ---
49  2002 Diagnosis of pulmonary pneumocystosis by microscopy on wet mount preparations. DIF, PCP
50  2002 Relevance of the selected cytokine release (TNF-alpha, IL-6, IFN-gamma, and IFN-alpha) to the exacerbation of bronchial asthma from airway mycotic infections. Predominant role of TFN-alpha? IFN-alpha, IFN-gamma, II-6, LPS, NDV, TNF-alpha
51  2001 Blood and alveolar lymphocyte subsets in pulmonary cytomegalovirus infection after lung transplantation. CMV
52  2001 Evidence that behavioral depression does not influence airway cell influx in allergic rats. OVA
53  2001 Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. i.g, PELF
54  2001 Role of IL-18 in acute lung inflammation. ---
55  2000 Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice. ---
56  2000 Immunohistochemical characterization of calf pneumonia produced by the combined endobronchial administration of bovine herpesvirus 1 and Pasteurella haemolytica. BHV-1
57  1999 Bronchoalveolar lavage fluid granulomas in a case of severe sarcoidosis. ---
58  1999 Detection of non-infectious conditions mimicking pneumonia in the intensive care setting: usefulness of bronchoalveolar fluid cytology. CFU, ICU
59  1999 Eotaxin expression in Sephadex-induced lung injury in rats. ---
60  1999 Respiratory tract inflammation during the induction of chronic bronchitis in rats: role of C-fibres. NL, ppm
61  1999 Role and Regulation of Chemokines in Rodent Models of Lung Inflammation. CINC, MCP-1, MIP-2, TNF-alpha
62  1998 Inhalation of cold air increases the number of inflammatory cells in the lungs in healthy subjects. IL
63  1997 Effect of 3 hours of passive smoke exposure in the evening on inflammatory markers in bronchoalveolar and nasal lavage fluid in subjects with mild asthma. ETS, NAL
64  1997 Effects of propentofylline on tumor necrosis factor-alpha and cytokine-induced neutrophil chemoattractant production in rats with cerulein-induced pancreatitis and endotoxemia. CINC, LPS, MPO, TNF
65  1997 Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury: role of endogenous IL-12. ---
66  1996 Cytokines in bronchoalveolar lavage fluid in patients with high altitude pulmonary oedema at moderate altitude in Japan. ARDS, HAPE, IL, LDH, RA, TNF
67  1996 Kinetics and dose dependence of macrophage colony-stimulating factor-induced proliferation and activation of murine mononuclear phagocytes in situ: differences between lungs, liver, and spleen. AM, M-CSF
68  1996 [A comparison of lymphocyte populations of the blood and bronchoalveolar lavage in AIDS patients]. ---
69  1995 Antioxidant therapy partially blocks immune-induced lung fibrosis. DMTU, SOD
70  1995 Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1-infected patients: evidence for genetic differences in HIV-1 between lung and blood macrophage populations. AM, HIV, PBM, PCR
71  1993 Bronchoalveolar lavage in allergic granulomatosis and angiitis. AGA, CEP
72  1993 Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma. NAL, SP
73  1993 [Cytomegalovirus infection after transplantation. Virological diagnosis, antiviral treatment]. CMV
74  1993 [The bactericidal effect of oxybuprocaine. A possible cause of false negative results in bronchoalveolar lavage]. ---
75  1992 Bronchial and bronchoalveolar lavage after allergen challenge in atopic patients. BL
76  1992 From alveoli back to bronchi. Contribution of bronchoalveolar (BAL) and bronchial (BL) lavage to the understanding of bronchial disease. International workshop. Verno, Italy, April 19-21, 1990. BL
77  1990 Concentration of tobramycin given by aerosol in the fluid obtained by bronchoalveolar lavage. ---
78  1989 Erdosteine protection against cigarette smoking-induced functional antiprotease deficiency in human bronchiolo-alveolar structures. EIC
79  1988 Relationship between serum neopterin and lymphocytic alveolitis in sarcoidosis. ---
80  1986 Alveolar macrophage stimulation of lung fibroblast growth in asbestos-induced pulmonary fibrosis. AMs, FGF